Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Aerosol: SOP for Conducting Swab Testing During Cleaning Validation – V 2.0

Posted on By

Aerosol: SOP for Conducting Swab Testing During Cleaning Validation – V 2.0

SOP for Conducting Swab Testing During Cleaning Validation

Department Aerosol
SOP No. SOP/Aerosol/129/2025
Supersedes SOP/Aerosol/129/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

This Standard Operating Procedure (SOP) outlines the process for conducting swab testing as part of cleaning validation for aerosol manufacturing equipment. Swab testing is used to verify the removal of residues, including active ingredients, cleaning agents, and contaminants, from the surfaces of equipment after cleaning. The purpose of this SOP is to ensure that swab testing is performed correctly and consistently, and that the equipment meets the established acceptance criteria for cleanliness.

2. Scope

This SOP applies to the use of swab testing as part of cleaning validation for aerosol manufacturing equipment. It covers the swabbing of surfaces that come into direct contact with the product, including filling machines, nozzles, valves, pumps, and containers. This SOP includes the preparation for swab testing, sample collection, analysis of the samples, and documentation of results.

3. Responsibilities

  • Production Team: Responsible for conducting the cleaning process and performing swab sampling according to this SOP after the cleaning procedure is complete.
  • Quality Assurance (QA) Team: Responsible for overseeing the swab testing process, ensuring compliance with this SOP, reviewing test results, and taking corrective
actions if necessary.
  • Validation Team: Responsible for ensuring that the swab testing method is validated and that the test results are documented properly in accordance with GMP standards.
  • Regulatory Affairs Team: Ensures that swab testing procedures meet regulatory requirements for aerosol manufacturing.
  • 4. Accountability

    The Manufacturing Manager is accountable for ensuring that swab testing is conducted as part of the cleaning validation process. The overall compliance with this SOP is overseen by the Quality Assurance (QA) Manager.

    5. Procedure

    5.1. Preparing for Swab Testing

    1. Before conducting swab testing, ensure that the cleaning process has been completed and that all equipment surfaces are accessible for testing.
    2. Ensure that all necessary materials and equipment for swab testing are available, including sterile swabs, solvent for swabbing (e.g., water or alcohol), sample collection containers, and labeling materials.
    3. Prepare the swab testing kit by ensuring that swabs are sterile, and the solvent used for swabbing is compatible with the residue being tested (e.g., cleaning agent or product residues).
    4. Verify that appropriate lighting and magnification tools are available to inspect the equipment surfaces during the testing process.
    5. Review the cleaning validation protocol to identify the specific surfaces to be swabbed, ensuring that critical areas are included in the swab testing process.

    5.2. Selecting Swab Sampling Points

    1. Identify the critical surfaces of the equipment that must be swabbed. These include surfaces that directly contact the product and those that are difficult to clean.
    2. Common sampling points include:
      • Filling nozzles, pumps, and valves
      • Internal surfaces of containers, tubes, and chambers
      • Surfaces that may retain product residues or cleaning agents after cleaning
    3. Ensure that the sampling plan is followed, including the number of swabs per equipment unit and the frequency of swabbing, as outlined in the cleaning validation protocol.

    5.3. Performing Swab Sampling

    1. Using a sterile swab, moisten the swab with an appropriate solvent (e.g., water or alcohol), ensuring that the swab is adequately wetted but not overly saturated.
    2. Swab the identified surfaces in a consistent manner, ensuring that all critical areas are covered. Use a systematic approach to swabbing, including making sure that the swab is applied evenly to the surface.
    3. After swabbing, place the swab in a sterile container and seal it to prevent contamination. Label the container with relevant information, including the batch number, sampling point, equipment cleaned, and the date and time of the sampling.
    4. Ensure that the swabbed surfaces are inspected for any visible residues before proceeding with the next sampling location.

    5.4. Analyzing the Swab Samples

    1. Once the swab samples are collected, they should be sent to the laboratory for analysis using validated methods. Common methods for analyzing swab samples include:
      • High-Performance Liquid Chromatography (HPLC): Used to detect and quantify product residues or cleaning agents.
      • Spectrophotometry: Used to detect cleaning agents or other contaminants based on their light absorption properties.
      • Titration: A method for measuring the concentration of cleaning agents or residual active ingredients on swabbed surfaces.
      • pH Measurement: Used to detect residual acidic or alkaline cleaning agents.
    2. Once the analysis is complete, compare the results to the established acceptance criteria, including residue limits and microbial contamination levels.
    3. If the results show that the residue levels exceed the acceptance criteria, further corrective actions should be taken as described in the Deviation Log (Annexure-2).

    5.5. Documenting the Swab Testing Results

    1. Document all swab testing activities in the Swab Testing Report (Annexure-1). The report should include:
      • The equipment cleaned and the specific sampling points swabbed
      • The solvent used for swabbing and the amount of solvent applied
      • The results of the swab sample analysis, including residue levels and any deviations from acceptance criteria
      • Any corrective actions taken if residue levels exceed the acceptance criteria
    2. Each swab testing report should be signed and dated by the person performing the testing and the person reviewing the results.
    3. The Swab Testing Report should be reviewed and approved by the QA team. Once approved, the report should be stored as part of the cleaning validation documentation.

    5.6. Corrective Actions for Deviations

    1. If the swab testing results show that the equipment does not meet the established cleanliness criteria, corrective actions should be taken. These may include:
      • Re-cleaning the equipment using the appropriate cleaning procedures.
      • Adjusting the cleaning process or agents to achieve better residue removal.
      • Performing additional sampling and testing to verify the effectiveness of the corrective actions.
    2. The corrective actions should be documented in the Deviation Log (Annexure-2), including the steps taken to address the deviation and the results of any subsequent testing.

    6. Abbreviations

    • GMP: Good Manufacturing Practice
    • QA: Quality Assurance
    • SOP: Standard Operating Procedure
    • HPLC: High-Performance Liquid Chromatography
    • CAPA: Corrective and Preventive Action

    7. Documents

    1. Swab Testing Report (Annexure-1)
    2. Deviation Log (Annexure-2)

    8. References

    This SOP is based on the following regulatory guidelines and industry standards:

    • Good Manufacturing Practice (GMP) Guidelines
    • FDA Code of Federal Regulations (CFR) Title 21, Part 211
    • International Council for Harmonisation (ICH) Guidelines

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Swab Testing Report

    Batch Number Test Date Residue Level Acceptance Criteria Result
    Batch-001 10/02/2025 Detergent Less than 5 ppm Pass

    Annexure-2: Deviation Log

    Deviation ID Deviation Description Corrective Action Assigned To Status
    DEV-12345 Residue above limit Adjusted cleaning procedure Rajesh Patel Completed

    12. Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By Page No. Ref. Point No. Details of Revision
    01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma Page 1 [Ref Point] First Release
    01/01/2025 V 2.0 Updated swab testing procedures To comply with updated GMP regulations Anjali Sharma Page 1 [Ref Point] Updated procedures
    See also  Aerosol: SOP for Cross-Contamination Prevention in Dispensing Areas - V 2.0
    Aerosols V 2.0 Tags:Aerosol Batch Production, Aerosol Can Design, Aerosol Cold Filling, Aerosol Documentation Standards, Aerosol Emissions Control, Aerosol Environmental Regulations, Aerosol equipment calibration, Aerosol Filling Process, Aerosol Fire Safety Measures, Aerosol Formulation, Aerosol Good Manufacturing Practice (GMP), Aerosol Hazardous Materials Handling, Aerosol Incident Reporting, Aerosol Leak Testing, Aerosol Maintenance Schedules, Aerosol Personal Protective Equipment (PPE), Aerosol Pressure Filling, Aerosol Product Labeling, Aerosol Product Testing, Aerosol Propellant Selection, Aerosol quality control, Aerosol Regulatory Compliance, Aerosol Risk Assessment, Aerosol Safety Protocols, Aerosol Standard Operating Procedures (SOPs), Aerosol Storage Requirements, Aerosol Training Programs, Aerosol Valve Crimping, Aerosol Ventilation Systems, Aerosol Waste Disposal

    Post navigation

    Previous Post: Creams: SOP for Microbial Testing of Cream Formulations – V 2.0
    Next Post: API Manufacturing: SOP for Vacuum Drying Procedure – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version